Physician profile
Thomas M Large
NPI 1407825318
$53,044.91
in general payments reported to CMS, 2019-2025
7 companies · $3,057 in 2025
The $3,057 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $6,583 · 2021: $5,062 · 2022: $4,890 · 2023: $7,311 · 2024: $11K · 2025: $3,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,740 · Travel and Lodging: $8,722 · Consulting Fee: $1,500 · Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,740.00 |
| Travel and Lodging | $8,721.70 |
| Consulting Fee | $1,500.00 |
| Food and Beverage | $1,003.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Synthes Gmbh | $52,189.89 | 2019-2025 | |
| Depuy Synthes Sales INC. | $370.54 | 2019-2025 | Na |
| Globus Medical, INC. | $169.04 | 2025 | Anthem |
| Zimmer Biomet Holdings, INC. | $142.96 | 2019-2021 | |
| Stryker Corporation | $128.32 | 2023-2025 | T2, Pelvis II, Asnis |
| Smith+Nephew, INC. | $44.16 | 2019-2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$137,750.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Large listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.